As of close of business last night, Cleanspark Inc’s stock clocked out at $15.60, down -1.83% from its previous closing price of $15.89. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 21467780 shares were traded.
Ratios:
To gain a deeper understanding of CLSK’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 64.39. For the most recent quarter (mrq), Quick Ratio is recorded 4.27 and its Current Ratio is at 4.29. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on December 08, 2023, Downgraded its rating to Neutral and sets its target price to $8 from $9 previously.
On October 31, 2023, Bernstein started tracking the stock assigning a Outperform rating and target price of $5.30.
On October 11, 2023, JP Morgan started tracking the stock assigning a Overweight rating and target price of $5.50.JP Morgan initiated its Overweight rating on October 11, 2023, with a $5.50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Schultz S. Matthew sold 367,000 shares for $23.07 per share. The transaction valued at 8,466,690 led to the insider holds 2,298,975 shares of the business.
Bradford Zachary sold 443,000 shares of CLSK for $8,997,330 on Mar 21 ’24. The CEO and President now owns 2,795,863 shares after completing the transaction at $20.31 per share. On Feb 27 ’24, another insider, Schultz S. Matthew, who serves as the Executive Chairman of the company, sold 322,400 shares for $20.95 each. As a result, the insider received 6,754,280 and left with 2,698,768 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSK now has a Market Capitalization of 3.52B and an Enterprise Value of 3.36B. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.40 while its Price-to-Book (P/B) ratio in mrq is 3.57. Its current Enterprise Value per Revenue stands at 15.52 whereas that against EBITDA is 55.58.
Stock Price History:
Over the past 52 weeks, CLSK has reached a high of $24.72, while it has fallen to a 52-week low of $2.38. The 50-Day Moving Average of the stock is 15.80, while the 200-Day Moving Average is calculated to be 8.46.
Shares Statistics:
It appears that CLSK traded 36.32M shares on average per day over the past three months and 33.59M shares per day over the past ten days. A total of 225.42M shares are outstanding, with a floating share count of 217.30M. Insiders hold about 3.60% of the company’s shares, while institutions hold 38.37% stake in the company. Shares short for CLSK as of Mar 15, 2024 were 23.2M with a Short Ratio of 0.64, compared to 24.56M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.71% and a Short% of Float of 12.08%.
Earnings Estimates
As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.04 for the current quarter, with a high estimate of $0.1 and a low estimate of -$0.02, while EPS last year was -$0.23. The consensus estimate for the next quarter is $0.01, with high estimates of $0.15 and low estimates of -$0.13.
Analysts are recommending an EPS of between $1.4 and $0.11 for the fiscal current year, implying an average EPS of $0.75. EPS for the following year is $0.98, with 4 analysts recommending between $2.59 and -$0.18.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for CLSK’s current fiscal year. The highest revenue estimate was $496M, while the lowest revenue estimate was $338.9M, resulting in an average revenue estimate of $417.27M. In the same quarter a year ago, actual revenue was $168.41M, up 147.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $764.26M in the next fiscal year. The high estimate is $1.31B and the low estimate is $459.2M. The average revenue growth estimate for next year is up 83.20% from the average revenue estimate for this year.
